We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Janssen Biotech is suing Celltrion and Hospira in the latest of a series of lawsuits related to its blockbuster Remicade (infliximab) therapy. Read More
GlaxoSmithKline and ViiV Healthcare redeemed a priority review voucher for their application for a single-tablet antiretroviral regimen of Tivicay (dolutegravir) and Edurant (rilpivirine) for maintenance treatment of HIV-1 infections. The voucher allows for an expedited six-month review — cutting four months from the standard review. Read More
The nation’s largest pharmacy benefits manager, Express Scripts, has sued Kaleo — maker of Evzio, an injectable emergency treatment for heroin and painkiller overdoses — claiming it owes nearly $15 million in fees and rebates. Read More